Skip to main content

Closed

AZTR: Azitra, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-109.0%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-31.9×

Current ratio6.94×

Azitra, Inc.

AZTRNew York Stock Exchange Arca·USD·Closed

Azitra, Inc.

AZTRNew York Stock Exchange Arca·USD·Closed

$0.14

+4.08%

$0.14

+$0.01 (4.08%)

52W Range

3thpctl

Volume

0.04×avg

Mkt Cap

1.48MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.04×avg

Market Cap

1.48MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings